The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Slater actually trading the rise it seems!
All Aim is high risk, yes.
But there's a lot of those that pay off nicely, ITS (as long as you hit out before it suspended) HE1, HUR all multi bagged nicely.
This has seen a huge decrease and is back on track with a very low Market cap, just like Westminster atm, yes in the past WSG was awful, but if you've seen the recent RNS there's a 10-15 year deal at a very nice turnover. They are set to see a good increase on non-dilution funding news.
APTA are also looking good for the future now, and I do believe there will be a few bags here, potentially even more...
But all I say is my own opinion and I always wish luck to those invested.
I don't go spouting about placing a bring needed with nothing that indicates that's the case.
Good luck holders.
You are not correct. I don't want a lower price per se. I'll take any price POST -funding!
I see you invest in WSG which must make you a very optimistic investor! I was an investor in that company for a number of years. It was full of empty promises and so I am amazed anyone is still investing in it. AIM is full of tripe. APTA is quite possibly just another basket case. It is ABSOLUTELY HIGH RISK.
Feels if you wanted a lower purchase price you should have brought last week.
If you're not invested then go elsewhere with your opinions.
No funding is needed, contracts are being sorted. The market cap is very undervalued here.
Good luck holders. This will rerate soon
To be 100% clear. We are NOT looking to raise funding. It's too soon to know if things will line up or not. We do NOT want any unnecessary dilution. As you will aware, having a shored up balance sheet in case of cash delays is safer and less controversial at a higher SP."
Fine, but I've seen that before and then a 'prudent' raise, and following that the company went bust! Saietta....
To me, the above statement is entirely consistent with a raise if the speculators propel the share p;rice higher, so I won't be back in quite yet. July is not far away and any raise would be sooner than that, if the money is required. So, I expect the SP here will be volatile for a while which reflects the underlying existential risk unless and until income related news is forthcoming. That's just me being sensible, so DYOR!
There are many reasons Nic Slater may have sold a small amount of his holdings, which we will probably never know.
The news flow here though suggests the company is firmly back on track and that the current Market cap after a horrible year is not reflecting the true value.
It will take time to gain the markets trust again but if that happens the SP will be at multiples of its current value.
Good luck holders
Superda
Posts: 193
Price: 0.675
Strong Buy
RE: Rocket loading!Today 07:50
Aaron says ‘no raising’
https://x.com/arrontolley/status/1775903597479256199?s=46&t=WuyCAqCnuctRxVwyXpOFyg
And the result of that conversation was Nic Slater reducing his holding :-(
We know categorically they have funds until July, when the new financial year (FY25) starts. After that is anybody's guess.
They are doing a great job of RNS-ing everything but the income related activities at the moment. Why?
There does appear to be a lot of potential here, but it's the near term tangible progress, which is shrouded in secrecy at the moment.
I think they still have sufficient funds at present and hopefully we'll see some deals done(only need one really) before any raise would be necessary. Either way the future looks promising.
An AIM CEO will forever and a day, say no placing up to the point when they need to.
If the company were to RNS the deals and income, maybe SH's could come to their own conclusion on that matter.
I don't think I'm sufficiently mentally unstable to start taking the word of an AIM CEO at face value just yet.
0.67p
What's worries me is fact he is selling at a loss which is out of character for him.I have known him a few years.Just hope this is not being pumped to get him to sell and take part in a placement ..hope I am wrong as holding a good chunk here ..on the flip side seem to coming together slowly
Aaron says ‘no raising’
https://x.com/arrontolley/status/1775903597479256199?s=46&t=WuyCAqCnuctRxVwyXpOFyg
Well, Aptamer have been working with ‘This’ pharmaceutical Company since 2020 on a ‘fee for service’ arrangement.
Clearly, it’s now developing into something potentially more significant and probably fair enough to let the market know that they are working with one of ‘The Majors’, which is useful to know, given that big pharma’s have deep pockets.
We know they are already working with AstraZeneca and are also working on a patent with Unilever.
I think we can assume this announcement relates to another major pharma.
I'm sure our optimism will attract the "doubters/derampers" but what the hell!
As, the sp is the current metric for measuring/anticipating market potential. As for me, I'm continuing to to increase my holding at the expense of a very long term adisapointnent.
There's not going to be a placing under 1p.
They are also still fine for cash currently.
This has such a large drop over the year, the Market cap is a joke.
This will easily see a few times the current SP soon.
Good luck
For not just humans but for every living creature....Just imagine....Far less "testing and associated pain" for all....especially for those who cannot explain how they are feeling.
I thought the "top pharma" rns was overly- rampy. Placing coming in my humble view!
It’s useful that Aaron has tweeted this, & good to know that their sales pipeline is not only growing, but they are closing deals.
This validates the likelihood that they have a good cash runway into 2025.
Furthermore, the Company is on the cusp of winning larger deals as outlined in the ‘Outlook & Summary’ section of the presentation, this was particularly interesting to hear how many ‘irons are in the fire’.
I noted too the discussion regarding peer valuations, and the fact a similar Company had been taken out for $6Bn, having obtained FDA approval for a discovery it had made.
So, in summary, potentially a great deal of upside from these levels.
Https://x.com/arrontolley/status/1782446952296173677?s=46&t=WuyCAqCnuctRxVwyXpOFyg
Get ready 🚀🚀🚀🚀
https://x.com/arrontolley/status/1782440925639180762?s=46&t=WuyCAqCnuctRxVwyXpOFyg
GLA
No, Nic Slater took a loss having bought in at the 1p placing.
That might explain today's lacklustre sp performance given how good the RNS was. Hopefully he's done selling for now so the sp can rise and stay there.
GLA
Seems that N Slater took some profits?? Sold about 0.80% of the Co.
For newcomers ( myself included) it’s well Worth watching the interim results for the Group via Investormeet, this is also published on YouTube.
There is clearly immense potential, the Unilever deal cannot be disclosed at this point but is clearly very exciting, and working with such a brand will
Open other doors.
The sales pipeline is growing £(2.9M) and cash balance of £1.8M at the end of Feb 2024 suggests a cash runway into 2025, ( assuming 50% conversion rate ) monthly burn is 300K.
2023 was difficult for the Company but it has turned a corner and momentum is building, if their heavily patented Optimal plus technology can be licensed to a Major Pharma then suddenly, this will breakout.
Plus a number of other opportunities gaining momentum.